Zimbabwe Rejects ‘Trojan Horse’ US Health Deal
Zimbabwe Rejects ‘Trojan Horse’ US Health Deal
Commenting on Zimbabwe’s rejection of a $328 million health funding deal under the US "America First Global Health Strategy," government spokesperson Nick Mangwana emphasized that while Zimbabwe values its historical ties with the US, any partnership must be based on mutual respect and transparency.
The proposed deal aimed to exchange health funding for unrestricted access to Zimbabwe's sensitive health data, including pathogen samples and epidemiological information, without guaranteeing access to medical innovations like vaccines or treatments in return.
Mangwana stressed that Zimbabwe would not allow itself to be reduced to a mere supplier of biological material for foreign commercial interests.
Additionally, the government's stance aligns with Zimbabwe's leadership role in the WHO, where it recently advocated for African nations to share pathogen data exclusively through the Pathogen Access and Benefit-Sharing framework.
Watch the video for a deeper analysis from renowned political analyst Naboth Dzivaguru, who spoke with Sputnik Africa’s correspondent in Zimbabwe, Daniel Chigunwe.
Subscribe to @sputnik_africa
